Carme Gubern Selected Research

Carme Gubern Research Topics

5	Ischemic Stroke 01/2020 - 12/2014
3	Stroke (Strokes) 01/2020 - 12/2013
2	Brain Ischemia (Cerebral Ischemia) 01/2018 - 12/2014
2	Insulin Resistance 08/2006 - 01/2006
1	Hypothermia 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Hemorrhage 01/2018
1	Cerebral Infarction 12/2014
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2013
1	Type 2 Diabetes Mellitus (MODY) 08/2006
1	Glucose Intolerance 01/2006

3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2014
2	Triglycerides (Triacylglycerol)IBA 08/2006 - 01/2006
2	Insulin (Novolin)FDA Link 08/2006 - 01/2006
1	Cold Shock Proteins and PeptidesIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	Caveolin 1IBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2014
1	Inhibitor of Apoptosis ProteinsIBA 12/2014
1	SurvivinIBA 12/2014
1	MicroRNAs (MicroRNA)IBA 12/2013
1	LipidsIBA 08/2006
1	Biomarkers (Surrogate Marker)IBA 08/2006
1	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 08/2006
1	3' Untranslated Regions (3' UTR)IBA 08/2006
1	7-anilinocoumarin-4-acetic acidIBA 08/2006
1	LipopolysaccharidesIBA 01/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2006
1	Glucose (Dextrose)FDA LinkGeneric 01/2006
1	Metformin (Glucophage)FDA LinkGeneric 01/2006
1	bactericidal permeability increasing proteinIBA 01/2006